Performance validation of Qualyscan®
– a novel tool for in situ proton therapy quality assurance
đź“… 18 September 2025
đź•‘ 2 PM (CEST)
⏳ 60 minutes
Join our new educational journey in proton therapy QA
Terapet SA, Switzerland and Skandion Clinic, Sweden are pleased to invite you to the first in a series of educational webinars exploring how innovation in quality assurance can enhance safety, accuracy, and confidence in proton therapy.
This premier session will introduce Qualyscan®, a groundbreaking solution for verification of the particle beam, with the potential to revolutionize QA in particle therapy.
By enabling the verification of the delivered beam, Qualyscan® addresses one of the key unmet needs in the field, enhancing precision and supporting improved treatment quality.
This is just the beginning: more expert-led sessions will follow, diving deeper into key aspects of beam range verification and image-guided particle therapy. Stay tuned!Â
Speaker
Prof. Alexandru Dasu
Professor in Medical Radiation Physics, Uppsala University | Head of Research and Development at the Skandion Clinic (Uppsala, Sweden)
Alexandru Dasu is a recognized authority in medical physics and particle therapy, with a career spanning clinical leadership and academic research. He is Professor at Uppsala University and serves as Head of Research and Development at the Skandion Clinic, Sweden’s national proton therapy center. Previously serving as Chief Medical Physicist at Skandion (2017–2025), he has also held senior academic roles at Linköping and Umeå Universities. His work focuses on proton therapy, radiobiological modeling, and the clinical integration of advanced dosimetric techniques, contributing to the evolution of precision radiotherapy across Europe.
Moderator
Prof. Dr. Raymond Miralbell
Medical Director, QuirĂłnsalud Proton Therapy Center (Madrid, Spain)
Raymond Miralbell is a leading radiation oncologist with over 40 years of clinical and academic experience in cancer treatment. Appointed Medical Director of the 1st Protontherapy facility in Spain, the Quirónsalud Proton Therapy Center in Madrid in 2018. Chairman and Professor at the Radiation Oncology Department of the University Hospital of Geneva (2007-2019), and Chairman of the Swiss Proton User’s Group (1997-2007), Prof. Miralbell has played a pivotal role in advancing precision radiotherapy and pediatric oncology, with numerous publications and contributions to international guidelines.
The webinar will cover:
A brief overview of today’s QA challenges in proton therapy
The role and potential ofÂ
in vivo range verification
Demo of Qualyscan® in action
Key results and insights from early applications
A look ahead on future developments and clinical integration
A live Q&A session
Receive the access link
